Sanders Morris Harris’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.44M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $895K | Hold |
|
|||||
|
2024
Q4 | $824K | Hold |
|
|||||
|
2024
Q3 | $963K | Hold |
|
|||||
|
2024
Q2 | $851K | Hold |
|
|||||
|
2024
Q1 | $523K | Hold |
|
|||||
|
2023
Q4 | $684K | Hold |
|
|||||
|
2023
Q3 | $625K | Hold |
|
|||||
|
2023
Q2 | $664K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $832K | Hold |
|
|||||
|
2022
Q3 | $688K | Hold |
|
|||||
|
2022
Q2 | $519K | Hold |
|
|||||
|
2022
Q1 | $572K | Hold |
|
|||||
|
2021
Q4 | $596K | Hold |
|
|||||
|
2021
Q3 | $714K | Hold |
|
|||||
|
2021
Q2 | $610K | Hold |
|
|||||
|
2021
Q1 | $492K | Hold |
|
|||||
|
2020
Q4 | $598K | Hold |
|
|||||
|
2020
Q3 | $514K | Buy |
|
|||||
|
2020
Q2 | $417K | Buy |
|